Follow the 우리바이오 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Food & Beverage sector, 우리바이오 has recorded 28 public disclosures. The latest transaction was reported on 9 January 2025 (Sale). Among the most active insiders: 박병헌. The full history is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
13 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.